BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
115.01
+1.24 (1.09%)
Dec 27, 2024, 1:57 PM EST - Market open
BioNTech SE Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 3,040 | 3,819 | 17,311 | 18,977 | 482.3 | 108.6 | Upgrade
|
| Revenue Growth (YoY) | -54.07% | -77.94% | -8.78% | 3834.63% | 344.11% | -14.87% | Upgrade
|
| Cost of Revenue | 476.9 | 599.8 | 2,995 | 2,912 | 59.3 | 17.4 | Upgrade
|
| Gross Profit | 2,563 | 3,219 | 14,316 | 16,065 | 423 | 91.2 | Upgrade
|
| Selling, General & Admin | 609.2 | 557.7 | 541.2 | 327.2 | 108.5 | 48.7 | Upgrade
|
| Research & Development | 2,220 | 1,783 | 1,537 | 949.2 | 645 | 226.5 | Upgrade
|
| Other Operating Expenses | 174.5 | -91.2 | 320.5 | 79.5 | -9.1 | -2.5 | Upgrade
|
| Operating Expenses | 3,004 | 2,250 | 2,399 | 1,356 | 744.4 | 272.7 | Upgrade
|
| Operating Income | -440.7 | 969.6 | 11,917 | 14,709 | -321.4 | -181.5 | Upgrade
|
| Interest Expense | -18.2 | -7.9 | -18.9 | -27.3 | -2 | -1.7 | Upgrade
|
| Interest & Investment Income | 357.6 | 357.6 | 48.5 | 1.5 | 1.6 | 1.8 | Upgrade
|
| Currency Exchange Gain (Loss) | -422.4 | -268 | 792.4 | 512.5 | -42.6 | 2.3 | Upgrade
|
| Other Non Operating Income (Expenses) | 303.4 | 162 | 216.8 | -277.8 | -20.4 | -0.3 | Upgrade
|
| EBT Excluding Unusual Items | -220.3 | 1,213 | 12,956 | 14,918 | -384.8 | -179.4 | Upgrade
|
| Legal Settlements | -97.6 | -29.4 | -3 | -9 | - | - | Upgrade
|
| Other Unusual Items | 2.2 | 2.2 | 1.4 | 137.2 | 239 | - | Upgrade
|
| Pretax Income | -315.7 | 1,186 | 12,954 | 15,046 | -145.8 | -179.4 | Upgrade
|
| Income Tax Expense | 151.2 | 255.8 | 3,520 | 4,754 | -161 | -0.2 | Upgrade
|
| Earnings From Continuing Operations | -466.9 | 930.3 | 9,434 | 10,293 | 15.2 | -179.2 | Upgrade
|
| Net Income to Company | - | 930.3 | 9,434 | 10,293 | 15.2 | -179.2 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | - | 0.1 | Upgrade
|
| Net Income | -466.9 | 930.3 | 9,434 | 10,293 | 15.2 | -179.1 | Upgrade
|
| Net Income to Common | -466.9 | 930.3 | 9,434 | 10,293 | 15.2 | -179.1 | Upgrade
|
| Net Income Growth | - | -90.14% | -8.34% | 67613.82% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 241 | 241 | 243 | 244 | 235 | 212 | Upgrade
|
| Shares Outstanding (Diluted) | 241 | 243 | 250 | 260 | 249 | 212 | Upgrade
|
| Shares Change (YoY) | -0.42% | -2.84% | -3.81% | 4.51% | 17.49% | 10.90% | Upgrade
|
| EPS (Basic) | -1.94 | 3.87 | 38.78 | 42.18 | 0.06 | -0.85 | Upgrade
|
| EPS (Diluted) | -1.94 | 3.83 | 37.77 | 39.63 | 0.06 | -0.85 | Upgrade
|
| EPS Growth | - | -89.86% | -4.69% | 65950.00% | - | - | Upgrade
|
| Free Cash Flow | 1,218 | 5,121 | 13,248 | 762.2 | -79.5 | -237.1 | Upgrade
|
| Free Cash Flow Per Share | 5.06 | 21.10 | 53.04 | 2.93 | -0.32 | -1.12 | Upgrade
|
| Gross Margin | 84.31% | 84.29% | 82.70% | 84.66% | 87.70% | 83.98% | Upgrade
|
| Operating Margin | -14.50% | 25.39% | 68.84% | 77.51% | -66.64% | -167.13% | Upgrade
|
| Profit Margin | -15.36% | 24.36% | 54.50% | 54.24% | 3.15% | -164.92% | Upgrade
|
| Free Cash Flow Margin | 40.07% | 134.10% | 76.53% | 4.02% | -16.48% | -218.32% | Upgrade
|
| EBITDA | -274.5 | 1,108 | 11,981 | 14,756 | -289 | -152.3 | Upgrade
|
| EBITDA Margin | -9.03% | 29.01% | 69.21% | 77.76% | -59.92% | -140.24% | Upgrade
|
| D&A For EBITDA | 166.2 | 138.2 | 64.5 | 46.2 | 32.4 | 29.2 | Upgrade
|
| EBIT | -440.7 | 969.6 | 11,917 | 14,709 | -321.4 | -181.5 | Upgrade
|
| EBIT Margin | -14.50% | 25.39% | 68.84% | 77.51% | -66.64% | -167.13% | Upgrade
|
| Effective Tax Rate | - | 21.57% | 27.17% | 31.59% | - | - | Upgrade
|
| Revenue as Reported | 3,819 | 3,819 | 17,311 | 18,977 | 482.3 | 108.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.